Mecwins was founded in 2008 as a spin-off of a research group from the Institute of Microelectronics of Madrid (IMM–CSIC), which is part of the Spanish Superior Council of Scientific Research in Spain. It has more than 10 years developing technological solutions to help scientists in the high impact research.
Mecwins uses its own technology to produce ultrahigh sensitive immunoassays for oncology, cardiovascular and infectious diseases.
Mecwins technology is based on a combination of nanomechanical sensing and plasmonic emission with a sandwich immunoassay. The detection limit achieved with our technology is at least one million lower than that achieved in routine clinical practice.

ReDIB is a singular scientific and technical infrastructure (ICTS) integrated by 4 different nodes: CIC biomaGUNE, CNIC, Hospital La Fe and UCM. The ICTS offers state-of-the-art imaging resources both at the pre-clinical and clinical levels to perform in vivo imaging studies at anatomical, physiological and molecular levels. In pre-clinical, Positron Emission Tomography (PET), Single Photon Emission Computerized Tomography (SPECT), Computerized Tomography (CT), Magnetic Resonance Imaging (MRI) and Optical Tomography are available. In clinical, the ICTS offers PET-MRI Imaging, CT and Ecocardiography equipment. Optical spectroscopy as micro/nanoscopy tools are also available. The facility is open to the research community and industrial entities who can access the different resources through an open and competitive call program.  (www.redib.net) for further information.